EARNEST Partners’s Pfizer PFE Stock Holding History

EARNEST Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,641	Closed	-$87.6K	–	875
2023 Q3	$87.6K	Hold	2,641	–	–	﹤0.01%	329
2023 Q2	$96.9K	Hold	2,641	–	–	﹤0.01%	310
2023 Q1	$108K	Hold	2,641	–	–	﹤0.01%	295
2022 Q4	$135K	Hold	2,641	–	–	﹤0.01%	290
2022 Q3	$116K	Hold	2,641	–	–	﹤0.01%	281
2022 Q2	$138K	Hold	2,641	–	–	﹤0.01%	273
2022 Q1	$137K	Hold	2,641	–	–	﹤0.01%	274
2021 Q4	$156K	Hold	2,641	–	–	﹤0.01%	269
2021 Q3	$114K	Hold	2,641	–	–	﹤0.01%	272
2021 Q2	$103K	Hold	2,641	–	–	﹤0.01%	276
2021 Q1	$96K	Hold	2,641	–	–	﹤0.01%	277
2020 Q4	$97K	Sell	2,641 -143	-5%	-$5.25K	﹤0.01%	273
2020 Q3	$97K	Hold	2,784	–	–	﹤0.01%	263
2020 Q2	$86K	Hold	2,784	–	–	﹤0.01%	265
2020 Q1	$86K	Hold	2,784	–	–	﹤0.01%	264
2019 Q4	$103K	Hold	2,784	–	–	﹤0.01%	268
2019 Q3	$95K	Hold	2,784	–	–	﹤0.01%	275
2019 Q2	$114K	Hold	2,784	–	–	﹤0.01%	268
2019 Q1	$112K	Hold	2,784	–	–	﹤0.01%	266
2018 Q4	$115K	Hold	2,784	–	–	﹤0.01%	259
2018 Q3	$116K	Hold	2,784	–	–	﹤0.01%	262
2018 Q2	$96K	Sell	2,784 -261	-9%	-$8.92K	﹤0.01%	266
2018 Q1	$103K	Hold	3,045	–	–	﹤0.01%	263
2017 Q4	$105K	Buy	+3,045	New	+$104K	﹤0.01%	255
2017 Q1	–	Sell	-3,045	Closed	-$94K	–	722
2016 Q4	$94K	Buy	+3,045	New	+$93K	﹤0.01%	244

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners's PFE Position: Q4 2023 in Review

EARNEST Partners sold out of Pfizer (PFE) in Q4 2023, closing a stake of 2,641 shares — an estimated $87.6K sold.

EARNEST Partners first reported a position in PFE in Q4 2016 and held it in 25 quarters. The position peaked at $156K in Q4 2021. 2,940 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

EARNEST Partners reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 2,641 Pfizer shares in Q4 2023, an estimated $87.6K.
EARNEST Partners first reported a position in Pfizer in Q4 2016 and held it in 25 quarters.
EARNEST Partners's Pfizer position peaked at $156K in Q4 2021.
2,940 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.